Legend Biotech Corp
NASDAQ:LEGN

Watchlist Manager
Legend Biotech Corp Logo
Legend Biotech Corp
NASDAQ:LEGN
Watchlist
Price: 39.89 USD 1.37% Market Closed
Market Cap: 7.4B USD
Have any thoughts about
Legend Biotech Corp?
Write Note

Legend Biotech Corp
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Legend Biotech Corp
Depreciation & Amortization Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Legend Biotech Corp
NASDAQ:LEGN
Depreciation & Amortization
$20.5m
CAGR 3-Years
27%
CAGR 5-Years
64%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Depreciation & Amortization
$8.4B
CAGR 3-Years
-1%
CAGR 5-Years
34%
CAGR 10-Years
27%
Gilead Sciences Inc
NASDAQ:GILD
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Depreciation & Amortization
$5.6B
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Depreciation & Amortization
$208.6m
CAGR 3-Years
20%
CAGR 5-Years
16%
CAGR 10-Years
12%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Depreciation & Amortization
$469.5m
CAGR 3-Years
20%
CAGR 5-Years
19%
CAGR 10-Years
25%

See Also

What is Legend Biotech Corp's Depreciation & Amortization?
Depreciation & Amortization
20.5m USD

Based on the financial report for Dec 31, 2023, Legend Biotech Corp's Depreciation & Amortization amounts to 20.5m USD.

What is Legend Biotech Corp's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
64%

Over the last year, the Depreciation & Amortization growth was 11%. The average annual Depreciation & Amortization growth rates for Legend Biotech Corp have been 27% over the past three years , 64% over the past five years .

Back to Top